PRESS RELEASE published on 02/14/2024 at 08:30, 1 year 9 months ago Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate. Study results confirm safety profile & effectiveness equal to standard care in reducing blood loss. Biotest aims to address global medical need with USD 800 million market potential Biotest AG Fibrinogen Concentrate Phase III Trial Study Results Medical Market Potential
PRESS RELEASE published on 11/28/2023 at 09:00, 2 years ago EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
PRESS RELEASE published on 11/02/2023 at 08:00, 2 years 1 month ago Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
PRESS RELEASE published on 10/05/2023 at 16:55, 2 years 1 month ago EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
PRESS RELEASE published on 10/05/2023 at 16:42, 2 years 1 month ago EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
PRESS RELEASE published on 09/21/2023 at 09:00, 2 years 2 months ago Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
PRESS RELEASE published on 09/12/2023 at 09:00, 2 years 2 months ago Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
PRESS RELEASE published on 09/07/2023 at 09:00, 2 years 2 months ago Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
PRESS RELEASE published on 09/05/2023 at 09:00, 2 years 3 months ago Biotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study
PRESS RELEASE published on 09/04/2023 at 12:10, 2 years 3 months ago Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years
Published on 12/05/2025 at 02:35, 10 hours 6 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 41 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 36 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 41 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 36 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 41 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 41 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 27 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 11 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 08:45, 3 hours 56 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 41 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 56 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 57 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
